About
About Genomic Vision Société Anonyme
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science research applications of single DNA molecules analysis and delivers fluorescence imaging; FiberSmart, an analysis software for replication combing assays; and accessories, which include combicoverslips, disposable DNA reservoirs, coverslips stickers, and bench holders. It offers FiberProbes; HexaCard, a genomic vision molecular combing technology offering a streamline one-stop-shop solution for biomanufacturing industries; TeloSizer, a novel tool for measurements of physical telomere length that can be applied to various model organisms; and EasyComb, EasyScan, and EasyComb Plus services. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Visit company website
5 years, 5 months ago
Genomic Vision Société Anonyme is currently in a long term downtrend where the price is trading 38.4% below its 200 day moving average.
From a valuation standpoint, the stock is 94.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.9.
Based on the above factors, Genomic Vision Société Anonyme gets an overall score of 1/5.